Search results
Camp Taylor near Modesto serves kids with heart ailments. How it overcame its own obstacles
Modesto Bee via Yahoo News· 5 days agoSamantha got tired easily until an operation last year that her parents hope will be her last. As...
MediciNova (NASDAQ:MNOV) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical ...
What Toxic Stress Can Do to Health
Medscape· 5 days agoIt starts early and lasts long.
Ghrelin Paradox: Unlocking New Avenues in Obesity Management
Medscape· 1 day agoGhrelin, the "hunger hormone," plays a key role in driving appetite and weight regain. Could...
Pioneering studies show promise in sequencing a baby’s genome at birth
Washington Post· 5 days agoThe caller said she had news about the infant’s genome, the complex genetic code found in virtually...
Gene Therapy Improves Vision in Rare, Inherited Eye Disorder
Medscape· 3 days agoEDIT-101, a CRISPR-based gene editing therapy, shows promise in patients with retinal degeneration...
Celine Dion offers a portrait of resilience in new documentary
KTBS Shreveport· 4 days agoThe 56-year old first disclosed in December 2022 that she had been diagnosed with Stiff Person ...
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...
FOX 23 News Albany· 4 days agoIn the results, olverembatinib showed excellent durable clinical benefits and favorable long-term tolerability in patients who had been treated with multiple TKIs (including ...
For Stenting in Calcified Lesions, Which Guide Is Best?
Medscape· 5 days agoIn the first randomized trial to compare imaging guidance for percutaneous interventions, optical...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 2 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of...